Status:

UNKNOWN

Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Acute Myelocytic Leukemia

Acute Lymphocytic Leukemia

Eligibility:

All Genders

Brief Summary

Bone marrow consists of a complex hematopoietic cellular component.When the blood progenitor cells differentiate to mature cells, they will exit unassisted to peripheral blood. On the other hand, the ...

Detailed Description

Bone marrow consists of a complex hematopoietic cellular component that continuously goes through self-replication and/or differentiation processes. When the blood progenitor cells differentiate to ma...

Eligibility Criteria

Inclusion

  • acute leukemia

Exclusion

  • nil

Key Trial Info

Start Date :

February 1 2003

Trial Type :

OBSERVATIONAL

End Date :

July 1 2004

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00155844

Start Date

February 1 2003

End Date

July 1 2004

Last Update

September 12 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Liang-In Lin

Taipei, Taiwan

Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" | DecenTrialz